Nasdaq Press Releases

IQSTEL, Inc. (N A S D A Q: IQST) $IQST Reports Record Q3 2025 Results with $102.8 Million Quarterly Revenue, 42% Sequential Growth and Strengthened Balance Sheet.

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) NRXP Also Reports Its Superior Preservative-Free IV Ketamine Now Submitted for FDA Abbreviated New Drug Application

Cycurion, Inc. (N A S D A Q: CYCU) $CYCU and IQSTEL (N A S D A Q: IQST) $IQST Strengthen Alliance by Retaining $1,000,000 Worth of Cross Holdings and Distribution of $500,000 of Shares to Their Own Shareholders

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP; $750 Million Market for Suicidal Depression Market Awaits

$430 Million 2026 Revenue Forecast for $IQST, 26% Organic Growth, and $500,000 Stock Dividend Highlight a Powerful AI & Digital Transformation Story

$NRXP Has Manufactured Multiple Commercial Lots of NRX-100 and KETAFREE™ with a Shelf Life of Three Years.

Ascent Solar Technologies, Inc. (N A S D A Q: ASTI) $ASTI Positioned to Serve the Rapidly Expanding $1 Trillion Global Space Economy Projected by 2040

Uni-Fuels Holdings Limited (N A S D A Q: UFG) $UFG Strengthens Global Presence in Dubai and Shanghai, Achieves ISCC Certification, and Raises Strategic Capital to Power Next-Stage Growth

Analyst D. Boral Targets NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP at $34 Per Share — Pioneering Breakthroughs in Treatment-Resistant Depression and Chronic Pain

H.C. Wainwright Initiates Coverage with $34 Price Target, Citing Paradigm Shift in Depression Treatment. NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP

Cybersecurity stocks: $cycu $goog $panw $zs $chkp $cybr $ffiv $crwd $ftnt $okta

Ascent Solar Technologies, Inc. (N A S D A Q: ASTI) $ASTI ….Longer Space Missions for NASA and Other Agencies. Longer Space Missions for NASA and Other Agencies via Agreement with CisLunar Industries

IQSTEL, Inc. (N A S D A Q: IQST) $IQST is Featured in Litchfield Hills Research Report with $18 price target on high-margin growth strategy

Cycurion, Inc. (N A S D A Q: CYCU) $CYCU Just Completed Restructuring Resulting in a Very Attractive OS Count of 2.88 Million Supporting Continued NASDAQ Listing and Higher Access to Institutional Investors

Phinge® Corporation is continuing to gauge market interest for a potential Regulation A+ offering, referred to as "testing the waters" under SEC Rule 255.

SEGG Media, Inc. (N A S D A Q: SEGG) $SEGG Has a Two-Year Roadmap to Sustain On-Chain Yield, Accelerate Tokenization and Embed Blockchain Infrastructure

AI-Driven Cybersecurity Innovator Cycurion, Inc. (N A S D A Q: CYCU) $CYCU Strengthens Balance Sheet, Expands Federal & Fortune 500 Partnerships, and Realigns for Institutional Investment

Professor Sergio Castro Vázquez of GestiónFinIA Analyzes Historic Market Momentum as S&P 500 Reaches 6,738 and Federal Reserve Prepares Rate Decision Amid U.S.-China Trade Developments

Phinge® Corporation is continuing to gauge market interest for a potential Regulation A+ offering, referred to as "testing the waters" under SEC Rule 255.

Aurelion (N A S D A Q: AURE) $AURE is Providing the Public and Institutions Access to Tokenized Gold as a Safe Haven to Inflation, Currency Devaluation and Crypto Volatility

IQSTEL, Inc. (N A S D A Q: IQST) $IQST Reports Record Q3 2025 Results with $102.8 Million Quarterly Revenue, 42% Sequential Growth and Strengthened Balance Sheet.

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) NRXP Also Reports Its Superior Preservative-Free IV Ketamine Now Submitted for FDA Abbreviated New Drug Application

Cycurion, Inc. (N A S D A Q: CYCU) $CYCU and IQSTEL (N A S D A Q: IQST) $IQST Strengthen Alliance by Retaining $1,000,000 Worth of Cross Holdings and Distribution of $500,000 of Shares to Their Own Shareholders

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP; $750 Million Market for Suicidal Depression Market Awaits

$430 Million 2026 Revenue Forecast for $IQST, 26% Organic Growth, and $500,000 Stock Dividend Highlight a Powerful AI & Digital Transformation Story

$NRXP Has Manufactured Multiple Commercial Lots of NRX-100 and KETAFREE™ with a Shelf Life of Three Years.

Ascent Solar Technologies, Inc. (N A S D A Q: ASTI) $ASTI Positioned to Serve the Rapidly Expanding $1 Trillion Global Space Economy Projected by 2040

Uni-Fuels Holdings Limited (N A S D A Q: UFG) $UFG Strengthens Global Presence in Dubai and Shanghai, Achieves ISCC Certification, and Raises Strategic Capital to Power Next-Stage Growth

Analyst D. Boral Targets NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP at $34 Per Share — Pioneering Breakthroughs in Treatment-Resistant Depression and Chronic Pain

H.C. Wainwright Initiates Coverage with $34 Price Target, Citing Paradigm Shift in Depression Treatment. NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP

Cybersecurity stocks: $cycu $goog $panw $zs $chkp $cybr $ffiv $crwd $ftnt $okta

Ascent Solar Technologies, Inc. (N A S D A Q: ASTI) $ASTI ….Longer Space Missions for NASA and Other Agencies. Longer Space Missions for NASA and Other Agencies via Agreement with CisLunar Industries

IQSTEL, Inc. (N A S D A Q: IQST) $IQST is Featured in Litchfield Hills Research Report with $18 price target on high-margin growth strategy

Cycurion, Inc. (N A S D A Q: CYCU) $CYCU Just Completed Restructuring Resulting in a Very Attractive OS Count of 2.88 Million Supporting Continued NASDAQ Listing and Higher Access to Institutional Investors

Phinge® Corporation is continuing to gauge market interest for a potential Regulation A+ offering, referred to as "testing the waters" under SEC Rule 255.

SEGG Media, Inc. (N A S D A Q: SEGG) $SEGG Has a Two-Year Roadmap to Sustain On-Chain Yield, Accelerate Tokenization and Embed Blockchain Infrastructure

AI-Driven Cybersecurity Innovator Cycurion, Inc. (N A S D A Q: CYCU) $CYCU Strengthens Balance Sheet, Expands Federal & Fortune 500 Partnerships, and Realigns for Institutional Investment

Professor Sergio Castro Vázquez of GestiónFinIA Analyzes Historic Market Momentum as S&P 500 Reaches 6,738 and Federal Reserve Prepares Rate Decision Amid U.S.-China Trade Developments

Phinge® Corporation is continuing to gauge market interest for a potential Regulation A+ offering, referred to as "testing the waters" under SEC Rule 255.

Aurelion (N A S D A Q: AURE) $AURE is Providing the Public and Institutions Access to Tokenized Gold as a Safe Haven to Inflation, Currency Devaluation and Crypto Volatility

$CYCU Initiates Legal Battle Against Naked Shorting and Defamation Aligns with Explosive Growth in AI-Driven Cybersecurity Contracts and a Shareholder Dividend via $1M Equity Alliance with IQSTEL

Ascent Solar Technologies, Inc. (N A S D A Q: ASTI) $ASTI is Positioned to Serve the Rapidly Expanding $1 Trillion Global Space Economy Projected by 2040

IQSTEL, Inc. (N A S D A Q: IQST) $IQST Featured in Litchfield Hills Research Report with $18 price target on high-margin growth strategy

Phinge® Corporation is announcing its intention to gauge market interest for a potential Regulation A+ offering, referred to as "testing the waters" under SEC Rule 255.

A Game-Changing Alliance Positions IQSTEL $IQST and $CYCU at the Vanguard of AI-Powered Cybersecurity for the Global Telecom and Fintech Landscape

Stock trading platforms can innovate into the app-less world of Netverse, to bring real-time trading together with universal rewards to set themselves apart from the rest of the industry.

SEGG Media (N A S D A Q: SEGG) $SEGG Media is Growing by Multi-Million Dollar Acquisitions Plan

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Refiles Abbreviated New Drug Application; $40 Price Target in New H. C. Wainright Research Report

SEGG Media (N A S D A Q: SEGG) $SEGG; $20 Price Target in Noble Capital Markets Report Also Has Deal Signed for NFL Yearbook Advertising Across 25 Stadiums

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Suitability Petition is required for shift from multidose packaging of ketamine to single-patient dose preservative free ketamine

IQSTEL, Inc. (N A S D A Q: IQST) $IQST $15 Million 2026 EBITDA Run Rate with $1 Billion 2027 Target Enhanced by Completed Fintech Acquisition